Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacopeial harmonization in biotechnology

R Dabbah, L T Grady

    Current Opinion in Biotechnology
    |August 1, 1998
    PubMed
    Summary
    This summary is machine-generated.

    Pharmacopeial harmonization efforts between the United States Pharmacopeia (USP), European Pharmacopoeia, and Japanese Pharmacopoeia are advancing. Progress is noted in monographs for excipients, biotech products, and general chapters, with a new USP initiative proposed.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Some studies of the stability of compounded cefazolin ophthalmic solution.

    International journal of pharmaceutical compounding·2013
    Same author

    The value of USP public standards for therapeutic products.

    Pharmaceutical research·2004
    Same author

    Activities of the USP Microbiology Subcommittee of Revision during the 1995-2000 revision cycle.

    PDA journal of pharmaceutical science and technology·2001
    Same author

    Revised USP standards for product dating, packaging, and temperature monitoring.

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2000
    Same author

    USP standards and activities affecting pharmacy practice.

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1997
    Same author

    Purity profiles of pteroylglutamate reference substances by high-performance liquid chromatography.

    Journal of pharmaceutical sciences·1982
    Same journal

    Microbial C1 assimilation pathways for chemical synthesis: from native metabolism to synthetic design.

    Current opinion in biotechnology·2026
    Same journal

    Medicinal plants fermentation: current knowledge and perspectives.

    Current opinion in biotechnology·2026
    Same journal

    Fermented foods: lessons learned from metagenomics.

    Current opinion in biotechnology·2026
    Same journal

    Microfluidic platforms for the transient transfection of mammalian cells: recent developments and challenges.

    Current opinion in biotechnology·2026
    Same journal

    Harvesting insights from recent advances in yeast genomics for predictable and precision wine fermentation.

    Current opinion in biotechnology·2026
    Same journal

    Minimal enzyme cascades for the aromatic-to-aromatic upgrading of lignin monomers.

    Current opinion in biotechnology·2026
    See all related articles

    Area of Science:

    • Pharmaceutical Sciences
    • Regulatory Science
    • Pharmacopeial Standards

    Background:

    • The global pharmaceutical industry relies on harmonized standards for drug quality and safety.
    • International pharmacopeias, including USP, EP, and JP, have engaged in harmonization initiatives.
    • Ensuring consistency in testing and assays across different regions is crucial for regulatory compliance.

    Purpose of the Study:

    • To report on the progress of pharmacopeial harmonization efforts.
    • To highlight advancements in harmonizing monographs for excipients and biotechnology-derived products.
    • To introduce the proposed Concordance of Foreign Pharmacopeial Tests and Assays initiative by USP.

    Main Methods:

    • Review of ongoing pharmacopeial harmonization processes.

    Related Experiment Videos

  • Analysis of progress in monograph development for specific product categories.
  • Description of the proposed USP initiative for foreign pharmacopeial test concordance.

    • Main Results:

    • Significant progress has been made in harmonizing general chapters and specific monographs.
    • Harmonization efforts encompass excipients and complex biotechnology-derived products.
    • The United States Pharmacopeia has proposed a new initiative for aligning foreign pharmacopeial tests and assays.

    Conclusions:

    • Pharmacopeial harmonization is advancing through collaborative efforts among major regulatory bodies.
    • Continued progress in harmonizing standards will facilitate global drug development and regulatory review.
    • The proposed USP initiative aims to further enhance consistency in international pharmacopeial testing.